Aptevo Therapeutics Inc.
USD5.02
-0.02 (-0.40%)
CEO
Jeffrey G. Lamothe
IPO Date
2016-07-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.31
Prev. Close
$5.04
Day Low
$5.00
Day High
$5.46
52W Low
$3.80
52W High
$235.98
Market Cap
$0.01B
Volume
0.12M
| 13,513 |
| $1.49 |
| 3 Oct 2025 | BANK OF AMERICA CORP /DE/ | 10 percent owner: | Disposed | 0 | $0.00 |
| 3 Oct 2025 | BANK OF AMERICA CORP /DE/ | 10 percent owner | Disposed | 0 | $0.00 |
| 8 Aug 2025 | Abdun-Nabi Daniel | director | A-Award | Acquired | 7,200 | $0.00 |
| 8 Aug 2025 | Taylor Daphne | SVP, CFO | A-Award | Acquired | 11,500 | $0.00 |
| 8 Aug 2025 | Grant Grady III | director | A-Award | Acquired | 7,200 | $0.00 |
| 8 Aug 2025 | Huebner Dirk | SVP, CMO | A-Award | Acquired | 11,500 | $0.00 |
| 8 Aug 2025 | Niederhuber John | director | A-Award | Acquired | 7,200 | $0.00 |
| 8 Aug 2025 | Lamothe Jeffrey G. | EVP, COO | A-Award | Acquired | 17,300 | $0.00 |